Showing 121 - 140 results of 428 for search '"Hepatitis B"', query time: 0.11s Refine Results
  1. 121

    Risk Prison and Hepatitis B Virus Infection among Inmates with History of Drug Injection in Isfahan, Iran by Daneshmand Dana, Nokhodian Zary, Adibi Peyman, Ataei Behrooz

    Published 2013-01-01
    “…Objectives. Hepatitis B virus (HBV) is a health problem among injection drug users (IDUs) in prison. …”
    Get full text
    Article
  2. 122

    Attitude and Vaccination Status of Healthcare Workers against Hepatitis B Infection in a Teaching Hospital, Ethiopia by Mohammed Akibu, Sodere Nurgi, Mesfin Tadese, Wendwesen Dibekulu Tsega

    Published 2018-01-01
    “…World Health Organization and Centers for Disease Control and Prevention recommend all health professionals to get vaccinated against hepatitis B virus before they start the clinical attachments during their stay in the medical school. …”
    Get full text
    Article
  3. 123

    Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma by Young Woon Kim, Jung Hyun Kwon, Eun Chung, Sung Won Lee, Jong-yul Lee, Jeong Won Jang, Kyu Won Chung, Soon Woo Nam

    Published 2015-01-01
    “…However, because of the resistance rate to telbivudine (TLV), the current guidelines recommend entecavir (ETV) or tenofovir (TNV) as the first-line therapy for chronic hepatitis B. We investigated the short term virologic efficacy of TLV in comparison with ETV as the first-line agent of HBV suppression in HBV-related advanced HCC patients. …”
    Get full text
    Article
  4. 124
  5. 125
  6. 126
  7. 127

    Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure by Xiaoping Wang, Caifei Shen, Jianjiang Yang, Xianjun Yang, Sen Qin, Haijun Zeng, Xiaoling Wu, Shanhong Tang, Weizheng Zeng

    Published 2018-01-01
    “…The value of alpha-fetoprotein (AFP) in hepatitis B-related acute-on-chronic liver failure (HBACLF) is not fully understood. …”
    Get full text
    Article
  8. 128
  9. 129

    The Efficacy of Mizoribine (Inosine Monophosphate Dehydrogenase Inhibitor) for ANCA-Associated Vasculitis with Hepatitis B Virus Carrier by Jun Muratsu, Atsuyuki Morishima, Masayoshi Kukida, Anzu Tanaka, Shigeki Fujita, Katsuhiko Sakaguchi

    Published 2012-01-01
    “…A 42-year-old female who was an asymptomatic carrier of hepatitis B virus (HBV) was diagnosed with antineutrophil cytoplasm antibody- (ANCA-) associated vasculitis and was induced to remission with 30 mg/day prednisolone nine years ago. …”
    Get full text
    Article
  10. 130
  11. 131
  12. 132
  13. 133

    Quantification of Pregenomic RNA and Covalently Closed Circular DNA in Hepatitis B Virus-Related Hepatocellular Carcinoma by Fugui Bai, Yoshihiko Yano, Takumi Fukumoto, Atsushi Takebe, Motofumi Tanaka, Kaori Kuramitsu, Nungki Anggorowati, Hanggoro Tri Rinonce, Dewiyani Indah Widasari, Masaya Saito, Hirotaka Hirano, Takanobu Hayakumo, Yasushi Seo, Takeshi Azuma, Yonson Ku, Yoshitake Hayashi

    Published 2013-01-01
    “…This study was aimed to measure hepatic pgRNA and cccDNA expression levels in various states of hepatitis B virus (HBV) infection. Thirty-eight hepatocellular carcinoma (HCC) patients, including 14 positive for hepatitis B surface antigen (HBsAg) and 24 negative for HBsAg but positive for anti-hepatitis B core (anti-HBc) antibody, were enrolled in this study. …”
    Get full text
    Article
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138

    Korelasi nilai mean platelet volume dengan derajat fibrosis hati pada pasien hepatitis B kronik by Sri Wayati Yuza

    Published 2020-04-01
    “…Nilai Mean Platelet Volume (MPV) yang terdapat dalam pemeriksaan darah rutin dapat dijadikan penanda keparahan fibrosis hati pada pasien hepatitis B kronik. Tujuan:  Menilai korelasi nilai MPV dan derajat fibrosis hati pada pasien hepatitis B kronik. …”
    Get full text
    Article
  19. 139

    Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients by Ioannis S. Elefsiniotis, Christos Pavlidis, Elena Vezali, Theodoros Mariolis-Sapsakos, Sotirios Koutsounas, George Saroglou

    Published 2009-01-01
    “…To evaluate the impact of hepatitis B core antibody (anti-HBc) seropositivity in sustained virological response (SVR) rates in treatment-naïve, chronic hepatitis C (CHC) patients with high pretreatment viral load (>800000 IU/mL). …”
    Get full text
    Article
  20. 140